Christine Fox, EVP, Head of U.S. Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 10,215 shares at $15.73 ($161K) on 2025-03-04, disclosed to the SEC on 2025-03-06.
Scheduled sale ($161k) by EVP, Head of U.S. Commercial under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.73 | 4,034 | $63K | 39.4% |
| 2 | $15.73 | 4,034 | $63K | 39.4% |
| 3 | $15.91 | 2,147 | $34K | 21.2% |
| Total | $15.77 avg | 10,215 | $161K | 100% |
| Filing → |
| TEVA | SELL | 2026-03-06 | $591K | — | Filing → |
| TEVA | SELL | 2025-11-24 | $1.4M | — | Filing → |
| TEVA | SELL | 2025-11-18 | $753K | — | Filing → |